| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aquestive Therapeutics, Inc. (AQST) has 17 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. AQST is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 660.6K | $3.11M | - | |
| Other | 366.7K | $1.73M | - | |
| CFO | 283.5K | $1.34M | - | |
| Other | 282.5K | $1.33M | - | |
| Other | 281.7K | $1.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2018 | Schobel Alexander Mark83 | Chief Innovation/ Tech Officer | Buy | 1,000 | $7.78 | $7,780.00 | - | |
| Dec 6, 2018 | Maxwell John T. | Svp-chief Financial Officer | Buy | 5,000 | $8.87 | $44,350.00 | +3.4% | |
| Dec 6, 2018 | Schobel Alexander Mark83 | Chief Innovation/ Tech Officer | Buy | 2,000 | $8.69 | $17,380.00 | +0.2% | |
| Nov 27, 2018 | Kendall Keith J | CEO And President | Buy | 1,000 | $9.87 | $9,870.00 | +0.2% | |
| Nov 27, 2018 | Braender Lori J | General Counsel | Buy | 1,000 | $10.57 | $10,570.00 | New | |
| Nov 26, 2018 | Wood Theresa | Svp-hr And Org. Development | Buy | 500 | $10.34 | $5,170.00 | +0.6% | |
| Nov 23, 2018 | Kendall Keith J | CEO And President | Buy | 7,950 | $10.10 | $80,325.00 | +0.6% | |
| Nov 21, 2018 | Maxwell John T. | Svp-chief Financial Officer | Buy | 10,000 | $9.80 | $98,000.00 | +7.2% | |
| Nov 21, 2018 | Schobel Alexander Mark83 | Chief Innovation/ Tech Officer | Buy | 1,000 | $10.25 | $10,250.00 | - | |
| Nov 21, 2018 | Boyd Peter E.84 | Svp-operations/ Value Delivery | Buy | 200 | $9.98 | $1,996.00 | +0.4% |